Find a Tender
complete
Official procurement procedure
OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack
Medical equipments
pharmaceuticals and personal care products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: BELFAST HEALTH AND SOCIAL CARE TRUST: "OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | BELFAST HEALTH AND SOCIAL CARE TRUST | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: BELFAST HEALTH AND SOCIAL CARE TRUST
Market Analytics
Derived from OCDS awards & bid statistics
Published history for BELFAST HEALTH AND SOCIAL CARE TRUST. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 16 active published awards; 16 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityBELFAST HEALTH AND SOCIAL CARE TRUST | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published20 Aug 2024, 15:44 BST | Last source update20 Aug 2024, 15:44 BST | Recurring procurementNot published |
ClassificationMedical equipments, pharmaceuticals and personal care products | ||
Delivery area | ||
OCIDocds-h6vhtk-049239 | ||
What is being bought
Procurement of OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack
What changed
From the official release history
- Status changed to complete
20 Aug 2024, 15:44 BST - Official notice release published
20 Aug 2024, 15:44 BST - Buyer information updated
20 Aug 2024, 15:44 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedProcurement of OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen PackContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
20 Aug 2024, 15:44 BST - Award active
Not published · Not published - Contract active
Signed 14 Aug 2024, 00:00 BST · £1,710,000
Commercial outcome and competition
Awards LLOYDS CLINICAL LIMITED Not published · Not published · active |
Contracts OFATUMUMAB (KESIMPTA) HOMECARE 20 mg in 0.4mL Pre-Filled Pen 1 Pen Pack £1,710,000 · signed 14 Aug 2024, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) |
Buyer and organisations in this procedure
BELFAST HEALTH AND SOCIAL CARE TRUST
Contracting authority GB-FTS-104485Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThese essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement. |